What are Amphastar Pharmaceuticals's profit margins?

Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.

Where do Amphastar Pharmaceuticals's ratios come from?

Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amphastar Pharmaceuticals AMPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	47.3%-3.2pp	49.5%-1.6pp	49.4%-3.6pp	49.9%-4.8pp	50.5%-3.8pp
Operating margin	16.2%-10.4pp	19.5%-8.6pp	20.7%-8.9pp	25.1%-7.1pp	26.6%-4.6pp
Net margin	11%-8.4pp	13.6%-8.2pp	15.4%-6.4pp	18.6%-4.7pp	19.4%-3.5pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.5×0.0×	0.5×0.0×	0.5×-0.1×
Liquidity
Current ratio	3.9×+0.9×	4×+0.9×	3.1×-0.3×	3.3×-0.2×	3×+0.8×
Leverage
Net debt / EBITDA	3×+1.1×	2.5×+0.5×	2.1×+0.5×	2×+0.4×	1.9×+0.2×
Valuation
Market capitalization	$926.83M-19.9%	$1.23B-31.1%	$1.24B-47.9%	$1.16B-40.8%	$1.38B-34.6%
Price / earnings	11.7×+3.5×	12.5×+1.4×	11.1×-4.0×	8.6×-3.1×	9.8×-3.9×
Price / sales	1.3×-0.3×	1.7×-0.7×	1.7×-1.6×	1.6×-1.1×	1.9×-1.2×
EV / EBITDA	8.3×+1.7×	8.7×-0.1×	8.2×-2.4×	6.9×-1.6×	7.5×-2.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amphastar Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amphastar Pharmaceuticals's profit margins?: Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
Where do Amphastar Pharmaceuticals's ratios come from?: Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.